News
MEDICAL SCIENTIFIC – METALTRONICA PARTNERSHIP
May 2024
In a significant advancement for women’s health, Medical Scientific and Metaltronica have announced a strategic partnership to introduce the FDA-approved Helianthus Mammography Screening System to the Tri-State Area. This state-of-the-art technology is positioned to bring cost effective breast cancer screening while providing women access to superior diagnostic tools.
The Helianthus Mammography Screening System is renowned for its cutting-edge imaging capabilities, offering unprecedented accuracy in the early detection of breast cancer. Its approval by the FDA underscores its efficacy and safety, marking a new era in mammography technology.
“We are thrilled to collaborate with Metaltronica to bring this groundbreaking system to the Tri-State Area,” said Stanley Sonkin, Project Manager of Medical Scientific. ” Our shared commitment to enhancing women’s health will significantly impact early detection and treatment outcomes for countless women.”
Metaltronica, a leader in medical imaging technology, has designed the Helianthus system to provide high-resolution images with lower radiation doses, ensuring patient safety and comfort. The system’s advanced features include automatic collimation, “Smart μ Press” compression and “POEt” and “SensROI” software to set the best exposure parameter, which allow for more detailed visualization of breast tissue.
“Partnering with Medical Scientific allows us to extend the reach of the Helianthus Mammography Screening System to a broader population,” said George Solomon, President of Metaltronica. “Together, we are dedicated to providing top-tier medical technology to enhance the quality of care and improve health outcomes for women.”
The introduction of the Helianthus system is expected to enhance the capacity and efficiency of mammography services across the Tri-State Area, ultimately contributing to better health outcomes through early detection and timely intervention. Women in New York, New Jersey, Pennsylvania and Connecticut can look forward to access to this advanced screening technology in the coming months.
This partnership marks a significant milestone in the ongoing effort to improve women’s health and underscores the importance of early detection in the fight against breast cancer. Medical Scientific and Metaltronica are committed to ensuring that women receive the best possible care through this innovative technology.